DIRECT SUPPLY SOLUTIONS LTD

What DIRECT SUPPLY SOLUTIONS LTD does

Direct Supply Solutions Ltd is a UK-based B2B distributor and administrative service provider focused on smoking cessation products. Founded in 2023 and headquartered in Stratford-Upon-Avon, the company supplies nicotine replacement therapy (NRT) products, CO monitors, e-cigarette products, and prescription medications including Varenicline, Bupropion, and Cytisine directly to healthcare and social service organizations across the United Kingdom. The company differentiates through an end-to-end service model that handles procurement, supply chain coordination, and delivery logistics, removing administrative burden from service providers so they can concentrate on patient-facing cessation support.

The business operates an enterprise-focused go-to-market with an account-request and demonstration-based sales motion. Pricing is not publicly disclosed and follows a quote-based, B2B model, suggesting contract-level engagements rather than transactional retail. The proprietary offering is described as an administrative integration rather than a software platform—the underlying technology stack disclosed is standard ASP.NET session management with Google Analytics for traffic analysis, and there are no app products, APIs, or AI features.

The company is privately held by founder/management, with Mark Lambourne serving as Director and data protection lead. There are no disclosed funding rounds, institutional investors, parent companies, or strategic partnerships, and the company operates exclusively within the UK domestic market. Revenue model is positioned as recurring supply contracts to healthcare providers, though no revenue, headcount, or customer figures have been disclosed.

Name

DIRECT SUPPLY SOLUTIONS LTD

Legal name

Direct Supply Solutions Ltd

Website

https://directsupplysolutions.co.uk

Company type

Private

Founded year

2023

Operating status

Operating

Short description

Direct Supply Solutions Ltd is a UK-based B2B distributor supplying smoking cessation products—including nicotine replacement therapy, CO monitors, e-cigarettes, and prescription medications—to healthcare and social service organizations, handling end-to-end procurement and delivery logistics.

Ownership category

akta.pro rank

Product category

Smoking Cessation Product Supply Services

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Smoking Cessation & Nicotine Replacement Therapy (NRT) (HLAIADAH)

akta.pro secondary industry

Direct-to-Provider / Clinic Buy-and-Bill Distributors (HLAIAJAM)

Keywords

• Smoking cessation products
• Nicotine replacement therapy
• Prescription medications supply
• Healthcare procurement services
• Managed distribution solutions

Headquarters

HQ city

Stratford-Upon-Avon

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Personnel, Operations, Marketing or Sales

Revenue model

1. Medical and pharmaceutical supplies sales: Direct sales of nicotine replacement therapy products, CO Monitors, e-cigarette products, and prescription medications (Varenicline, Bupropion, Cytisine) to healthcare and social service organizations.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Direct Supply Solutions supplies a comprehensive range of smoking cessation quit aids — nicotine replacement therapy products, CO monitors, e-cigarette products, and prescription medications (Varenicline, Bupropion, Cytisine) — directly to healthcare and social service organizations. The company wraps this in an end-to-end administrative service that handles ordering, delivery, and logistics so service providers can focus on patient care.

Product overview

Direct Supply Solutions Ltd operates as a single unified product/service offering centered on smoking cessation. The company provides an end-to-end solution combining nicotine replacement therapy products (patches, gum, lozenges), CO Monitors, e-cigarette products, and prescription medications (Varenicline, Bupropion, Cytisine). Their core value proposition is administrative simplification—handling all procurement, supply chain, and delivery logistics so that healthcare service providers can focus on patient care while ensuring service users receive the right products at the right time.

Differentiator

Problem solved

Functional benefit

Products and services

• Nicotine Replacement Therapy (NRT) Products

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators1 record

Recent moves4 records

Expansion highlights2 records

Direct peers

• Clinigen Group: Clinigen provides specialty pharmaceutical services including access, distribution, and managed supply of medicines directly to healthcare providers, including unlicensed and specialty products. Comparable as a B2B supplier handling end-to-end procurement and delivery logistics of niche therapeutic products to provider organisations.
• Sciensus: Sciensus is a UK specialty pharmaceutical distributor delivering medicines and clinical services directly to patients and providers, with strong logistics capabilities and recurring supply relationships. Comparable as a UK-focused specialty distributor managing end-to-end fulfillment for healthcare providers.
• HealthNet Homecare: HealthNet Homecare is a UK homecare pharmacy and clinical services provider distributing medicines directly to patients at home and supporting NHS services. Comparable as a UK B2B distributor integrating supply chain, dispensing, and provider-facing service for therapeutic categories.

Broad incumbents

• Alliance Healthcare: Alliance Healthcare, part of Walgreens Boots Alliance, is a major UK pharmaceutical distributor serving pharmacies, hospitals, and clinics with full-line medicines and consumer health products including smoking cessation lines. Comparable as a broad-line wholesale channel competing for the same B2B provider customers.
• Phoenix Group (AAH Pharmaceuticals): Phoenix Group, the UK's largest pharmaceutical wholesaler operating through AAH Pharmaceuticals, supplies hospitals, community pharmacies, and dispensing doctors with a broad range of prescription and OTC medicines including NRT. It is the dominant incumbent against which a niche smoking-cessation distributor must compete for provider contracts.

Others

• Lloyds Pharmacy (Pharmacy2U): Lloyds Pharmacy is a large UK pharmacy chain selling OTC NRT and dispensing prescription cessation medications to patients, often in partnership with NHS services. Comparable as an alternative retail and provider channel through which smoking cessation products reach UK end users.
• Johnson & Johnson Innovative Medicine (UK): J&J's pharma division historically marketed nicotine cessation products and related prescription aids, supplying UK healthcare channels. Comparable as an upstream manufacturer of therapies that DSS supplies to providers.
• Stop Smoking Services / NHS Tobacco Dependence Treatment: NHS-commissioned stop smoking services and local authority public-health teams are the primary downstream customers of smoking cessation product distributors in the UK. Comparable as the demand-side counterpart whose procurement decisions determine volumes for distributors.
• Haleon (Nicorette / Nicotinell manufacturer): Haleon is the consumer healthcare manufacturer behind leading OTC NRT brands such as Nicorette and Nicotinell. Comparable as an upstream supplier whose products flow through distributors like Direct Supply Solutions into UK smoking cessation services.

Regional players

• Ethypharm UK (now Neuraxpharm): Neuraxpharm (including the former Ethypharm UK) is a European specialty pharmaceutical company with smoking cessation and addiction products, including Cytisinicline/Cytisine. Comparable as a participant in the UK prescription smoking cessation supply chain that DSS distributes.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DIRECT SUPPLY SOLUTIONS LTD